With an accuracy rating of 98 percent, specially-trained dogs were able to smell volatile organic compounds (VOCs) released into urine by prostate tumors, setting the stage for a potentially new means of early prostate cancer detection, according to a new study at the 109thAnnual Scientific Meeting of the American Urological Association (AUA). The study will be presented to the media during a special press conference on Sunday, May 18 at 1:00 p.m. at the Orange County Convention Center, Orlando, FL.
You probably learned in school that cancer is caused by the mutation of cells that grow out of control causing tumors.
This view was first suggested in 1928 and has held pretty fast in the minds of the medical and scientific communities for some 85 years, despite the fact that this mutation theory has been proven true for less than 10 percent of cancers.
InSightec was established in January 1999. The company developed a breakthrough technology that in essence allows treating human beings without cutting the body. We developed technological systems that allows the destruction of targets deep inside the body completely non-invasive.
A landmark paper was recently published in one of the most prestigious human medical journals, Pigment Cell and Melanoma Research. This study, partially funded by Animal Cancer Foundation (www.acfoundation.org) showed that oral and digital melanomas in dogs serve as a model for certain aggressive melanomas in people.
In the quest for better cancer medicines, vaccines that treat rather than prevent disease are getting lots of attention. More than 90 clinical trials have tested therapeutic vaccines in cancer patients, but the results have been a mixed bag. A recent study in mice suggests that changing a traditional ingredient in the vaccines could make a big difference.
Dr. Clare Knottenbelt is a professor at the College of Medical, Veterinary and Life Sciences at the University of Glasgow, Scotland, where her recent research involves assessing hair nicotine in dogs exposed to secondhand smoke. She answers this week's questions.